FTC Commissioners Rohit Chopra and Becca Kelly Slaughter prominently cite recent research by our Partner Prof. Dr. Justus Haucap in their statements on the Federal Trade Commission clears Bristol-Myers Squibb acquisition of Celgene.
The cited studies can be found here:
Justus Haucap, Joel Stiebale [2016], Research: Innovation Suffers When Drug Companies Merge, HARVARD BUSINESS REVIEW [Aug. 3, 2016]